Novartis receives EU approval for Ilaris® in patients suffering acute …

Data from two Phase III trials and their extensions, which supported the EU approval for Ilaris in acute gouty arthritis attacks, showed that patients treated with Ilaris experienced significantly greater pain relief compared to the injectable … Ilaris has been assessed for the treatment of acute gouty arthritis attacks in two multicentre, randomized , double-blind, active- controlled studies in patients with frequent gouty arthritis attacks (>=3 in the previous year) who were unable ..

Read the original post: 
Novartis receives EU approval for Ilaris® in patients suffering acute …

No comments yet.

TOP